SlideShare a Scribd company logo
1 of 20
Mortality Audit
01-12-2022
What are Morbidity and Mortality
meetings?
Morbidity and Mortality meetings
(M&Ms) or clinical review meetings
allow departments/ specialties/
facilities to review the quality of the
care that is being provided to their
patients.
M&Ms are a key opportunity for
clinical staff to engage in the processes
of patient safety and quality
improvement and therefore represent
an important opportunity for
education regarding these processes
as well as for senior staff to model
appropriate professional behaviour.
Objectives
The objectives of a well-run M&M conference are to
identify adverse outcomes associated with medical error,
modify behavior and judgment based on previous
experiences, and prevent repetition of errors leading to
complications. Conferences are non-punitive and focus on
the goal of improved patient care. The proceedings are
generally kept confidential by law.
Meeting atmosphere conducive to open discussion with a
focus on “Just Culture” with an emphasis on the system,
not on individuals.
Shared understanding and enabling a positive
accountability team culture
Personal Details of the patient:
Final Diagnosis
Chronic Liver Disease (Alcohol
Related) – Decompensated with
Encephalopathy and Septic
Shock.
Critical Time
Line
• Date and time of admission onto Casualty:
23/11/22 7:10 pm
• Date and Time of Shifting to ward: HDU,
23/11/22 8:20 pm
• Any other shifts within wards: N/A
• Option of going to higher center given: Yes
• Date and Time of Death: 25/11/22, 1:05 pm
• Time Interval b/t admission & death: 41hrs
55min
Was the patient DNR: Yes,
Futility of care (Non-
availability of ventilators at
the time of admission)
Was it discussed with
family: Yes
History and Examination:
Chief complaints:
Abdominal distension
(insidious onset, no pain) &
Yellowish discoloration of
the sclera (no n pruritic).
Vitals: HR: 112, RR: 28, BP:
90/80, Spo2: Initially 71%-
later 92% with O2.
System: CVS: s1s2 +, RS:
Coarse Crepitations +, GI:
Abdomen Distended+++,
Gross ascites+++, CNS: E4
V4 M5
Provisional Diagnosis at Admission:
Chronic Alcoholic Liver disease in Shock with ARDS
Investigations:
• Hb: 10.8, TLC: 2.74, N: 91%, Platelets: 1.18 thousand.
• Creatinine: 1.08, Na: 127, K: 4.0
• LFT: Total Billirubin: 1.2, Direct. B: 0.5, Total Protein: 6.4, Albumin: 2.2
• AST: 51, ALT: 29, ALP: 104, INR: 1.89
• Ascitic Fluid: WBC: 50, DLC: Mostly Lymphocytes, Albumin: 0.6
• ABG: pH: 7.1, pCo2: 68.8, pO2: 65, HCO3: 23.7, SO2: 84%, Lactate: 3.64, BE: -5
ECG: N/A
CXR: B/L
pleural effusion
USG: N/A CT SCAN:N/A
Treatment
Given:
Inj. Piptaz 4.5g stat and Q8H
Inj.Pantop/ optineuron
Inj.Hydrocortisone
Inj. Vit K
Inj. Tranexa
Lactulose Enema
Course during hospitalization:
23/11/22
7: 10 pm: The patient was admitted to the ER after an
initial assessment by the duty doctor; Poor prognosis of
the patient and the non-availability of ventilator support
were explained to the patient relatives.
8:20 pm: patient shifted to HDU
24/11/22
12:35 am: Patient restless and desaturating: seen by the
duty doctor, BP: 120/90, SO2: 88%, PR: 120, O2 support
and Inj.Hydrocortisone given.
Morning Consultant Rounds: Patient Gasping, Diagnosed
to have lower GI bleed. Noradrenalin was started because
of BP: 80/50, Inj. Albumin, Inj. Octreotide was given, NIV-
BiPAP was started, and Hb checked Q8H.
24/11/22
Evening: Blood Culture Report: gram-positive
cocci, Streptococcus Pneumoniae. Low urine
output(50 ml/ 12 hrs).
The patient is still on NIV and octreotide, and
noradrenalin infusion.
25/11/22
5 am: patient desaturated; relatives opted for
DNI, Noradrenalin at 40 mcg/min, octreotide
12.5
1pm: patient declared dead
Most
Important
treatment/
drugs for
the patient:
Pitaz
Hydrocortisone
Octreotide
Noradrenalin
NIV-BiPAP
• Time Interval b/w patient’s arrival in hospital and treatment /drugs
given: 15 min
• Was there any delay in treatment/drugs given: Yes
Antibiotics given after 1 hr, (1 hr 40 min
Delay in correction of Investigations: No
Documentation
• History & Examination: Adequate
• Doctor’s Orders: Adequate
• Operation notes: N/A
• Consent: Inadequate, High-risk consent
taken, No consent for Ascitic tap(probably
missed or misplaced).
• Death notes: Inadequate
• MLC Documentation: N/A
• Death certificate: N/A
Deficiencies in
Care Seen: Delay
in First does of
antibiotics
(Modifiable)
Technical: Non-
availability of
ventilator
(Limited
resource)- Not-
easily modifiable
Judgemental:
N/A
Monitoring: N/A
How can the Deficiencies be improved upon
the First dose of I/V
antibiotics should be
given immediately after
taking cultures – Gold
standard- within 1hr.
Re-check by nursing staff
if there is any deficient
documentation before
shifting the patient from
CR to ward/HDU.
Lessons
Learnt
Intravenous antibiotics, in case of
Sepsis, should be given at the
earliest possible time, preferably
within 1 hr, to decrease morbidity
and Mortality.
Check has to be made by the
nursing staff to ensure all
documents including consent forms
present in the file.
Potential Legal
implications?
N/A
Thank You
- Karthik Thangamuthu

More Related Content

What's hot

Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadNephroTube - Dr.Gawad
 
Delayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshirDelayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshirMoh'd sharshir
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...NephroTube - Dr.Gawad
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadNephroTube - Dr.Gawad
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadNephroTube - Dr.Gawad
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadNephroTube - Dr.Gawad
 
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...NephroTube - Dr.Gawad
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadNephroTube - Dr.Gawad
 
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. GawadIntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. GawadNephroTube - Dr.Gawad
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. GawadNephroTube - Dr.Gawad
 
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...NephroTube - Dr.Gawad
 
Aki an overview
Aki an overviewAki an overview
Aki an overviewFAARRAG
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd PrescriptionMNDU net
 
The Management of Gout and Hyperuricemiadbm
The Management of Gout and HyperuricemiadbmThe Management of Gout and Hyperuricemiadbm
The Management of Gout and Hyperuricemiadbmstrategy6
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI Manish Singla
 
Induction agents in renal transplantation
Induction agents in renal transplantationInduction agents in renal transplantation
Induction agents in renal transplantationVishal Golay
 

What's hot (20)

ABO incompatible renal transplant
ABO incompatible renal transplantABO incompatible renal transplant
ABO incompatible renal transplant
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Delayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshirDelayed Graft Function post kidney transplant, Moh'd sharshir
Delayed Graft Function post kidney transplant, Moh'd sharshir
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Autoimmune Hepatitis
Autoimmune HepatitisAutoimmune Hepatitis
Autoimmune Hepatitis
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
 
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
Non EPO Management of Renal Anemia - Different Lines & Available Evidence - D...
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
 
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. GawadIntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
IntraDialytic Hypertension (Basic Science → Evidence → Practice) - Dr. Gawad
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
 
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome (Questions & ...
 
Aki an overview
Aki an overviewAki an overview
Aki an overview
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
The Management of Gout and Hyperuricemiadbm
The Management of Gout and HyperuricemiadbmThe Management of Gout and Hyperuricemiadbm
The Management of Gout and Hyperuricemiadbm
 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
 
Induction agents in renal transplantation
Induction agents in renal transplantationInduction agents in renal transplantation
Induction agents in renal transplantation
 

Similar to Mortality Audit.pptx

Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...
Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...
Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...UC San Diego AntiViral Research Center
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot campderosaMSKCC
 
Back to the Bedside: Internal Medicine Bedside Ultrasound Program
Back to the Bedside: Internal Medicine Bedside Ultrasound ProgramBack to the Bedside: Internal Medicine Bedside Ultrasound Program
Back to the Bedside: Internal Medicine Bedside Ultrasound ProgramAllina Health
 
Preoperative Preparations
Preoperative PreparationsPreoperative Preparations
Preoperative Preparationshanisahwarrior
 
8. nhựt english
8. nhựt english8. nhựt english
8. nhựt englishvinhvd12
 
Preoperative Prepration in General Surgery Patients
Preoperative Prepration in  General Surgery PatientsPreoperative Prepration in  General Surgery Patients
Preoperative Prepration in General Surgery PatientsDr Mubashir Bashir
 
Journal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptxJournal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptxMyThaoAiDoan
 
PEDIATRIC DEPARTMENT
PEDIATRIC DEPARTMENTPEDIATRIC DEPARTMENT
PEDIATRIC DEPARTMENTDipali Liman
 
Colonoscopy Complications
Colonoscopy ComplicationsColonoscopy Complications
Colonoscopy ComplicationsJarrod Lee
 
Rj gi bleed,khomeini
Rj gi bleed,khomeiniRj gi bleed,khomeini
Rj gi bleed,khomeinifikri asyura
 
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...EvanGloriaPolii
 
Mortality Audit presentation - slid.pptx
Mortality Audit presentation - slid.pptxMortality Audit presentation - slid.pptx
Mortality Audit presentation - slid.pptxssuser504dda
 
Advanced hfref pearls
Advanced hfref pearlsAdvanced hfref pearls
Advanced hfref pearlsdrucsamal
 
The Kidney Transplantation Patient Pathway at the QEHB
The Kidney Transplantation Patient Pathway at the QEHBThe Kidney Transplantation Patient Pathway at the QEHB
The Kidney Transplantation Patient Pathway at the QEHBmeducationdotnet
 

Similar to Mortality Audit.pptx (20)

CHARES.pptx
CHARES.pptxCHARES.pptx
CHARES.pptx
 
Emergencies in oncology
Emergencies in oncologyEmergencies in oncology
Emergencies in oncology
 
Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...
Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...
Cryptococcal Meningitis with Cranial Nerve Neuropathies: Predictors of Outcom...
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot camp
 
Back to the Bedside: Internal Medicine Bedside Ultrasound Program
Back to the Bedside: Internal Medicine Bedside Ultrasound ProgramBack to the Bedside: Internal Medicine Bedside Ultrasound Program
Back to the Bedside: Internal Medicine Bedside Ultrasound Program
 
Preoperative Preparations
Preoperative PreparationsPreoperative Preparations
Preoperative Preparations
 
organoph.pptx
organoph.pptxorganoph.pptx
organoph.pptx
 
GNRS 583 Care plan
GNRS 583 Care planGNRS 583 Care plan
GNRS 583 Care plan
 
organoph 1.pptx
organoph 1.pptxorganoph 1.pptx
organoph 1.pptx
 
8. nhựt english
8. nhựt english8. nhựt english
8. nhựt english
 
Preoperative Prepration in General Surgery Patients
Preoperative Prepration in  General Surgery PatientsPreoperative Prepration in  General Surgery Patients
Preoperative Prepration in General Surgery Patients
 
Journal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptxJournal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptx
 
PEDIATRIC DEPARTMENT
PEDIATRIC DEPARTMENTPEDIATRIC DEPARTMENT
PEDIATRIC DEPARTMENT
 
Colonoscopy Complications
Colonoscopy ComplicationsColonoscopy Complications
Colonoscopy Complications
 
Rj gi bleed,khomeini
Rj gi bleed,khomeiniRj gi bleed,khomeini
Rj gi bleed,khomeini
 
05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss
05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss
05.29.20 | Owen Clinic Case: A Man with Constipation and Weight Loss
 
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...
MR D Rose - Hepatitis B - CKD 5 - CHF - Hipertensi - Dislipidemia - Hiperuris...
 
Mortality Audit presentation - slid.pptx
Mortality Audit presentation - slid.pptxMortality Audit presentation - slid.pptx
Mortality Audit presentation - slid.pptx
 
Advanced hfref pearls
Advanced hfref pearlsAdvanced hfref pearls
Advanced hfref pearls
 
The Kidney Transplantation Patient Pathway at the QEHB
The Kidney Transplantation Patient Pathway at the QEHBThe Kidney Transplantation Patient Pathway at the QEHB
The Kidney Transplantation Patient Pathway at the QEHB
 

Recently uploaded

Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...DrShinyKajal
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersShafnaP5
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsNaveen Gokul Dr
 
duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///sofia95y
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Lachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptxLachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptxMUHAMMADZAHID314
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stocktammysayles9
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineAarishRathnam1
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesPHARMA IQ EDUCATION
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfLearnyoga
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxDr. Rabia Inam Gandapore
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 

Recently uploaded (20)

Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Lachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptxLachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptx
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 

Mortality Audit.pptx

  • 2. What are Morbidity and Mortality meetings? Morbidity and Mortality meetings (M&Ms) or clinical review meetings allow departments/ specialties/ facilities to review the quality of the care that is being provided to their patients. M&Ms are a key opportunity for clinical staff to engage in the processes of patient safety and quality improvement and therefore represent an important opportunity for education regarding these processes as well as for senior staff to model appropriate professional behaviour.
  • 3. Objectives The objectives of a well-run M&M conference are to identify adverse outcomes associated with medical error, modify behavior and judgment based on previous experiences, and prevent repetition of errors leading to complications. Conferences are non-punitive and focus on the goal of improved patient care. The proceedings are generally kept confidential by law. Meeting atmosphere conducive to open discussion with a focus on “Just Culture” with an emphasis on the system, not on individuals. Shared understanding and enabling a positive accountability team culture
  • 4. Personal Details of the patient:
  • 5. Final Diagnosis Chronic Liver Disease (Alcohol Related) – Decompensated with Encephalopathy and Septic Shock.
  • 6. Critical Time Line • Date and time of admission onto Casualty: 23/11/22 7:10 pm • Date and Time of Shifting to ward: HDU, 23/11/22 8:20 pm • Any other shifts within wards: N/A • Option of going to higher center given: Yes • Date and Time of Death: 25/11/22, 1:05 pm • Time Interval b/t admission & death: 41hrs 55min
  • 7. Was the patient DNR: Yes, Futility of care (Non- availability of ventilators at the time of admission) Was it discussed with family: Yes History and Examination: Chief complaints: Abdominal distension (insidious onset, no pain) & Yellowish discoloration of the sclera (no n pruritic). Vitals: HR: 112, RR: 28, BP: 90/80, Spo2: Initially 71%- later 92% with O2. System: CVS: s1s2 +, RS: Coarse Crepitations +, GI: Abdomen Distended+++, Gross ascites+++, CNS: E4 V4 M5
  • 8. Provisional Diagnosis at Admission: Chronic Alcoholic Liver disease in Shock with ARDS Investigations: • Hb: 10.8, TLC: 2.74, N: 91%, Platelets: 1.18 thousand. • Creatinine: 1.08, Na: 127, K: 4.0 • LFT: Total Billirubin: 1.2, Direct. B: 0.5, Total Protein: 6.4, Albumin: 2.2 • AST: 51, ALT: 29, ALP: 104, INR: 1.89 • Ascitic Fluid: WBC: 50, DLC: Mostly Lymphocytes, Albumin: 0.6 • ABG: pH: 7.1, pCo2: 68.8, pO2: 65, HCO3: 23.7, SO2: 84%, Lactate: 3.64, BE: -5
  • 9. ECG: N/A CXR: B/L pleural effusion USG: N/A CT SCAN:N/A
  • 10. Treatment Given: Inj. Piptaz 4.5g stat and Q8H Inj.Pantop/ optineuron Inj.Hydrocortisone Inj. Vit K Inj. Tranexa Lactulose Enema
  • 11. Course during hospitalization: 23/11/22 7: 10 pm: The patient was admitted to the ER after an initial assessment by the duty doctor; Poor prognosis of the patient and the non-availability of ventilator support were explained to the patient relatives. 8:20 pm: patient shifted to HDU 24/11/22 12:35 am: Patient restless and desaturating: seen by the duty doctor, BP: 120/90, SO2: 88%, PR: 120, O2 support and Inj.Hydrocortisone given. Morning Consultant Rounds: Patient Gasping, Diagnosed to have lower GI bleed. Noradrenalin was started because of BP: 80/50, Inj. Albumin, Inj. Octreotide was given, NIV- BiPAP was started, and Hb checked Q8H.
  • 12. 24/11/22 Evening: Blood Culture Report: gram-positive cocci, Streptococcus Pneumoniae. Low urine output(50 ml/ 12 hrs). The patient is still on NIV and octreotide, and noradrenalin infusion. 25/11/22 5 am: patient desaturated; relatives opted for DNI, Noradrenalin at 40 mcg/min, octreotide 12.5 1pm: patient declared dead
  • 14. • Time Interval b/w patient’s arrival in hospital and treatment /drugs given: 15 min • Was there any delay in treatment/drugs given: Yes Antibiotics given after 1 hr, (1 hr 40 min Delay in correction of Investigations: No
  • 15. Documentation • History & Examination: Adequate • Doctor’s Orders: Adequate • Operation notes: N/A • Consent: Inadequate, High-risk consent taken, No consent for Ascitic tap(probably missed or misplaced). • Death notes: Inadequate • MLC Documentation: N/A • Death certificate: N/A
  • 16. Deficiencies in Care Seen: Delay in First does of antibiotics (Modifiable) Technical: Non- availability of ventilator (Limited resource)- Not- easily modifiable Judgemental: N/A Monitoring: N/A
  • 17. How can the Deficiencies be improved upon the First dose of I/V antibiotics should be given immediately after taking cultures – Gold standard- within 1hr. Re-check by nursing staff if there is any deficient documentation before shifting the patient from CR to ward/HDU.
  • 18. Lessons Learnt Intravenous antibiotics, in case of Sepsis, should be given at the earliest possible time, preferably within 1 hr, to decrease morbidity and Mortality. Check has to be made by the nursing staff to ensure all documents including consent forms present in the file.
  • 20. Thank You - Karthik Thangamuthu